Progress on the Discovery of Inhibitors of InhA, the FAS II Enoyl-ACP Reductase TB Drug Discovery Targeted on InhA

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 6, 2016-06 ,pp. : 539-546

Bentham Science Publishers

Access to resources Recommend Favorite

Enoyl ACP Reductase as Effective Target for the Synthesized Novel Antitubercular Drugs: A-State-of-the-Art

By  

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 8, 2014-06 ,pp. : 678-693

Bentham Science Publishers

Access to resources Recommend Favorite

Slow-Onset Inhibition of 2-trans-Enoyl-ACP (CoA) Reductase from Mycobacterium tuberculosis by an Inorganic Complex

By  

Current Pharmaceutical Design, Vol. 12, Iss. 19, 2006-07 ,pp. : 2409-2424

Bentham Science Publishers

Access to resources Recommend Favorite

The Mode of Inhibition of Mycobacterium tuberculosis Wild-Type and Isoniazid-Resistant 2-Trans-Enoyl-ACP(CoA) Reductase Enzymes by An Inorganic Complex

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 7, Iss. 1, 2008-01 ,pp. : 50-62

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR and Molecular Docking Studies of Pyrazole Derivatives as Inhibitors of Enoyl Acyl Carrier Protein Reductase from Mycobacterium tuberculosis

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 4, 2017-02 ,pp. : 414-433

Bentham Science Publishers

Access to resources Recommend Favorite